Horrell Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Horrell Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-66	Closed	-$2K	–	174
2017 Q1	$2K	Hold	66	–	–	﹤0.01%	165
2016 Q4	$2K	Hold	66	–	–	﹤0.01%	164
2016 Q3	$3K	Hold	66	–	–	﹤0.01%	158
2016 Q2	$3K	Hold	66	–	–	﹤0.01%	171
2016 Q1	$4K	Hold	66	–	–	﹤0.01%	162
2015 Q4	$4K	Hold	66	–	–	﹤0.01%	160
2015 Q3	$4K	Hold	66	–	–	﹤0.01%	178
2015 Q2	$4K	Hold	66	–	–	﹤0.01%	183
2015 Q1	$4K	Hold	66	–	–	﹤0.01%	289
2014 Q4	$4K	Hold	66	–	–	﹤0.01%	293
2014 Q3	$4K	Hold	66	–	–	﹤0.01%	288
2014 Q2	$3K	Hold	66	–	–	﹤0.01%	299
2014 Q1	$3K	Hold	66	–	–	﹤0.01%	276
2013 Q4	$3K	Hold	66	–	–	﹤0.01%	276
2013 Q3	$2K	Hold	66	–	–	﹤0.01%	276
2013 Q2	$3K	Buy	+66	New	+$2.57K	﹤0.01%	282

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Horrell Capital Management's TEVA Position: Q2 2017 in Review

Horrell Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2017, closing a stake of 66 shares — an estimated $2K sold.

Horrell Capital Management first reported a position in TEVA in Q2 2013 and held it in 16 quarters. The position peaked at $4K in Q1 2016. 650 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

Horrell Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2017 after selling out during the quarter.
Horrell Capital Management sold 66 Teva Pharmaceutical Industries Limited shares in Q2 2017, an estimated $2K.
Horrell Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 16 quarters.
Horrell Capital Management's Teva Pharmaceutical Industries Limited position peaked at $4K in Q1 2016.
650 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2017.

Based on Horrell Capital Management's 13F filing for Q2 2017, filed 14 Jul 2017.